Targeted metabolomics in neurodegenerative diseases
March 23rd, 2021 |
04:00 pm CET (11:00 am EST)
Dr. Barbara Ustaszewski
biocrates life sciences ag
During this event you will learn
- Why Alzheimer’s disease can only be understood by looking at the metabolic perspective.
- How different disease stages can be characterized by their metabolic signature.
- How absolute quantification of biological metabolites empowers the discovery of deeper pathophysiological insights with direct clinical relevance.